Israeli IceCure Expands Cancer Treatment Technology in Netherlands
Israeli firm IceCure Medical partners with Scovas Medical for exclusive distribution of its ProSense cryoablation cancer treatment in the Netherlands.
ProSense
Israeli Tumor-Freezing Technology Gains Ground in Brazil
IceCure Medical's tumor-freezing ProSense technology is gaining commercial traction in Brazil for breast, lung, kidney, and musculoskeletal tumors.
Israeli Medtech Firm IceCure Gains FDA Approval for Post-Market Breast Cancer Study
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".
Navigation